Who
Christopher Van Tuyl
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Immunovant.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $2.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Dec 2024
- Last trade
- 7 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Oct 2026filed 9 Oct 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $43K1,327 at $32.06 | filing |
| 23 Sep 2026filed 25 Sep 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $103K2,846 at $36.36 | filing |
| 23 Sep 2026filed 25 Sep 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $103K2,846 at $36.36 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $45K1,143 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $2,51963 at $39.99 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $45K1,143 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $2,51963 at $39.99 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code M | $271K17,824 at $15.20 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $572K14,982 at $38.19 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $111K2,842 at $38.96 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,824 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,824 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code M | $271K17,824 at $15.20 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $572K14,982 at $38.19 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $111K2,842 at $38.96 | filing |
| 18 Jun 2026filed 22 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $93K2,634 at $35.39 | filing |
| 18 Jun 2026filed 22 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $93K2,634 at $35.39 | filing |
| 8 Apr 2026filed 10 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $128K5,165 at $24.83 | filing |
| 8 Apr 2026filed 10 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $128K5,165 at $24.83 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —41,343 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.